Don’t invest unless you’re prepared to lose all the money you invest. Investment opportunities presented by Animal Health Angels are high-risk, and you’re unlikely to be protected if something goes wrong. Take 2 mins to learn more
MI:RNA

Wednesday, December 10, 2025

Multi-million dollar funding round accelerates MI:RNA mission to improve global veterinary diagnostics

Pioneering molecular diagnostics company MI:RNA, which uses biomarkers and advanced modelling to diagnose veterinary disease earlier, has reached a growth milestone with the completion of an oversubscribed funding round.

Photo Antigenesis

Friday, December 5, 2025

AHA Welcomes Antigenesis, Developing New Cancer Therapies for Pets.

Antigenesis joins the AHA portfolio with a focus on creating targeted antibody-based cancer treatments for pets. With early funding secured and lead molecules in preclinical development, the company is working to bring new options to a fast-growing area of veterinary medicine.

Canister image

Friday, December 5, 2025

SageTech Medical Secures £3.6m Innovate UK Funding

We are delighted to congratulate SageTech Medical, one of our portfolio companies, on securing £3.6 million in funding through Innovate UK's prestigious Grand Challenge programme.